Literature DB >> 8254404

Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection.

B Goins1, R Klipper, A S Rudolph, R O Cliff, R Blumhardt, W T Phillips.   

Abstract

We have recently developed a procedure to label liposomes containing reduced glutathione (GSH) with 99mTc using the lipophilic chelator, hexamethylpropyleneamine oxime (HMPAO). In the present study, we evaluated the use of 99mTc-liposomes to detect focal infection sites in rats. Rats were infected in the thigh by intramuscular injection with Staphylococcus aureus followed 24 hr later by an intravenous injection of 99mTc-liposomes, 67Ga-citrate, or 99mTc-human serum albumin (HSA). The animals were imaged under a gamma camera and subsequently killed at 4, 24 or 48 hr for tissue biodistribution studies. In contrast to infected rats receiving 67Ga-citrate or 99mTc-HSA, abscesses were prominently localized within 2 hr in rats after 99mTc-liposome injection, and continued to increase in activity up to 24 hr. Abscess-to-muscle ratios calculated from 24-hr biodistribution data obtained from tissue sampling were 35.3 +/- 7.6 for 99mTc-liposomes, 4.1 +/- 0.7 for 67Ga-citrate and 8.0 +/- 1.0 for 99mTc-HSA. These studies show the potential of using 99mTc-liposomes to localize infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254404

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

Review 1.  The uptake mechanisms of inflammation- and infection-localizing agents.

Authors:  W J Oyen; O C Boerman; C J van der Laken; R A Claessens; J W van der Meer; F H Corstens
Journal:  Eur J Nucl Med       Date:  1996-04

2.  Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model.

Authors:  H Agashe; P Lagisetty; K Sahoo; D Bourne; B Grady; V Awasthi
Journal:  J Nanopart Res       Date:  2011-06-01       Impact factor: 2.253

Review 3.  Theranostic Nanoparticles for Tracking and Monitoring Disease State.

Authors:  Cristina Zavaleta; Dean Ho; Eun Ji Chung
Journal:  SLAS Technol       Date:  2017-11-08       Impact factor: 3.047

4.  Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model.

Authors:  C J van der Laken; O C Boerman; W J Oyen; M T van de Ven; R A Claessens; J W van der Meer; F H Corstens
Journal:  Eur J Nucl Med       Date:  1995-11

Review 5.  Nuclear molecular imaging with nanoparticles: radiochemistry, applications and translation.

Authors:  D S Abou; J E Pickett; D L J Thorek
Journal:  Br J Radiol       Date:  2015-07-02       Impact factor: 3.039

Review 6.  Molecular Imaging and Nanotechnology-Emerging Tools in Diagnostics and Therapy.

Authors:  Marcin Woźniak; Agata Płoska; Anna Siekierzycka; Lawrence W Dobrucki; Leszek Kalinowski; Iwona T Dobrucki
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

7.  Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using (99m)Tc-HMPAO.

Authors:  Do Won Hwang; Hongyoon Choi; Su Chul Jang; Min Young Yoo; Ji Yong Park; Na Eun Choi; Hyun Jeong Oh; Seunggyun Ha; Yun-Sang Lee; Jae Min Jeong; Yong Song Gho; Dong Soo Lee
Journal:  Sci Rep       Date:  2015-10-26       Impact factor: 4.379

8.  99mTc-radiolabeled Levofloxacin and micelles as infection and inflammation imaging agents.

Authors:  Mine Silindir-Gunay; Asuman Yekta Ozer
Journal:  J Drug Deliv Sci Technol       Date:  2020-02-08       Impact factor: 3.981

Review 9.  Chemically Modified Extracellular Vesicles and Applications in Radiolabeling and Drug Delivery.

Authors:  Elisa-Racky N'Diaye; Nicola Salvatore Orefice; Catherine Ghezzi; Ahcène Boumendjel
Journal:  Pharmaceutics       Date:  2022-03-16       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.